PMVP

PMV Pharmaceuticals, Inc.

1.58 USD
-0.03 (-1.86%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PMV Pharmaceuticals, Inc. stock is down -1.86% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 July’s closed higher than June.

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc. engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function.